Patients accept therapy using embryonic stem cells for Parkinson’s disease: a discrete choice experiment

Patients accept therapy using embryonic stem cells for Parkinson’s disease: a discrete choice experiment

Abstract Background New disease-modifying ways to treat Parkinson’s disease (PD) may soon become a reality with intracerebral transplantation of cell products produced from human embryonic stem cells (hESCs). The aim of this study was to assess what factors influence preferences of patients with PD...

Full description

Bibliographic Details
Main Authors: Karin Schölin Bywall, Jennifer Drevin, Catharina Groothuis-Oudshoorn, Jorien Veldwijk, Dag Nyholm, Hakan Widner, Trinette van Vliet, Elena Jiltsova, Mats Hansson, Jennifer Viberg Johansson
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Medical Ethics
Subjects:
Ethics
Human embryonic stem cells
Parkinson’s disease
Patient preferences
Online Access:https://doi.org/10.1186/s12910-023-00966-1

Internet

https://doi.org/10.1186/s12910-023-00966-1

Similar Items